Jazz Pharmaceuticals
JAZZ
#1899
Rank
โ‚ฌ8.85 B
Marketcap
145,76ย โ‚ฌ
Share price
1.67%
Change (1 day)
25.86%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2025 (TTM): -โ‚ฌ0.59 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ4.15 Billion. In 2024 the company made an earning of โ‚ฌ0.40 Billion, an increase over its 2023 earnings that were of โ‚ฌ0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.59 Billion-246%
2024 โ‚ฌ0.40 B57.87%
2023 โ‚ฌ0.25 B-179.92%
2022 -โ‚ฌ0.33 Billion230.37%
2021 -โ‚ฌ96.92 Million-141.02%
2020 โ‚ฌ0.23 B-39.45%
2019 โ‚ฌ0.39 B-14.2%
2018 โ‚ฌ0.45 B20.03%
2017 โ‚ฌ0.37 B-17.15%
2016 โ‚ฌ0.45 B22.14%
2015 โ‚ฌ0.37 B187.64%
2014 โ‚ฌ0.13 B-50.79%
2013 โ‚ฌ0.26 B73.63%
2012 โ‚ฌ0.15 B41.69%
2011 โ‚ฌ0.10 B116.61%
2010 โ‚ฌ49.63 M262.77%
2009 โ‚ฌ13.68 M-111.33%
2008 -โ‚ฌ0.13 Billion1.31%
2007 -โ‚ฌ0.12 Billion77.8%
2006 -โ‚ฌ67.04 Million36.59%
2005 -โ‚ฌ49.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Endo International
ENDPQ
-โ‚ฌ2.06 Billion 240.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
AmerisourceBergen
ABC
โ‚ฌ1.80 B-398.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ14.10 B-2,435.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.52 B-352.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel